ALK G1269A
|
NSCLC
|
ALK G1269A
|
NSCLC
|
alectinib Sensitive: C3 – Early Trials
|
alectinib Sensitive: C3 – Early Trials
|
ALK G1269A
|
NSCLC
|
ALK G1269A
|
NSCLC
|
ensartinib Resistant: C3 – Early Trials
|
ensartinib Resistant: C3 – Early Trials
|
ALK G1269A
|
NSCLC
|
ALK G1269A
|
NSCLC
|
crizotinib Resistant: C3 – Early Trials
|
crizotinib Resistant: C3 – Early Trials
|
ALK G1269A
|
NSCLC
|
ALK G1269A
|
NSCLC
|
ceritinib Sensitive: D – Preclinical
|
ceritinib Sensitive: D – Preclinical
|